Bosh sahifa069620 • KRX
add
Daewoong Pharma
Yopilish kursi
138 000,00 ₩
Kunlik diapazon
137 400,00 ₩ - 144 700,00 ₩
Yillik diapazon
100 100,00 ₩ - 164 400,00 ₩
Bozor kapitalizatsiyasi
1,66 trln KRW
Oʻrtacha hajm
26,25 ming
Narx/foyda
66,48
Dividend daromadliligi
0,42%
Bozor yangiliklari
Barron's
1 kun oldin
Berkshire Stock Could Drop 99% and Still Top S&P 500 Over Buffett’s 60-Year Reign
1,81%
1,47%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 367,88 mlrd | 1,67% |
Joriy xarajat | 153,50 mlrd | -0,07% |
Sof foyda | -12,83 mlrd | -119,44% |
Sof foyda marjasi | -3,49 | -119,13% |
Har bir ulushga tushum | — | — |
EBITDA | 49,28 mlrd | 26,41% |
Amaldagi soliq stavkasi | -17,59% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 116,35 mlrd | -15,50% |
Jami aktivlari | 1,98 trln | 11,67% |
Jami passivlari | 1,05 trln | 22,37% |
Umumiy kapital | 926,98 mlrd | — |
Tarqatilgan aksiyalar | 11,51 mln | — |
Narxi/balansdagi bahosi | 2,00 | — |
Aktivlardan daromad | 4,61% | — |
Kapitaldan daromad | 5,66% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -12,83 mlrd | -119,44% |
Operatsiyalardan naqd pul | 22,59 mlrd | 66,72% |
Sarmoyadan naqd pul | -78,23 mlrd | -9,58% |
Moliyadan naqd pul | 60,32 mlrd | 113,83% |
Naqd pulning sof oʻzgarishi | 8,38 mlrd | 125,97% |
Boʻsh pul | -56,45 mlrd | -8,02% |
Haqida
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Tashkil etilgan
1945
Sayt
Xodimlar soni
1 727
